Skip to content

Fai una donazione

Sostieni la ricerca per il diabete!

Studi e lavori AMD

AMD ANNALI (2006-19)

  • Per la lista completa degli articoli e delle pubblicazioni Annali, si rimanda alla specifica sezione dello spazio online Annali AMD.

AMD REMINDERS

Standard italiani per la cura del diabete mellito

Gli articoli relativi agli Standard di cura sono consultabile nella specifica sezione (alla voce: «Archivio pubblicazioni sugli “Standard italiani per la cura del diabete mellito”»).

Studio BENCH-D

  • Nicolucci A, Rossi MC, Pellegrini F, Lucisano G, Pintaudi B, Gentile S, Marra G, Skovlund SE, Vespasiani G; BENCH-D Study Group. Benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study: protocol, tools, and population.
    Springerplus. 2014 Feb 12;3:83
  • Rossi MC, Lucisano G, Funnell M, Pintaudi B, Bulotta A, Gentile S, Scardapane M, Skovlund SE, Vespasiani G, Nicolucci A; BENCH-D Study Group. Interplay among patient empowerment and clinical and person-centered outcomes in type 2 diabetes. The BENCH-D study.
    Patient Educ Couns. 2015 Sep;98(9):1142-9
  • Pintaudi B, Lucisano G, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, Rossi MC, Nicolucci A; BENCH-D Study Group. Correlates of diabetes-related distress in type 2 diabetes: Findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) study

Studio BETADECLINE

  • Russo TG, Giorda CB, Cercone S, Nicolucci A, Cucinotta D; BetaDecline Study Group. Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.
    PLoS One. 2014 Oct 27;9(10):e109702
  • Giorda CB, Russo GT, Cercone S, De Cosmo S, Nicolucci A, Cucinotta D. Incidence and correlated factors of beta cell failure in a 4-year-follow-up of patients with type 2 diabetes A longitudinal analysis of the BETADECLINE Study.
    Acta Diabetologica, First online: 18 May 2016

Studio DEMAND

  • Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda CB, Valentini U, Vespasiani G, De Cosmo S. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.
    Nephrol Dial Transplant. 2008 Apr;23(4):1278-84
  • Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Pomili B, Valentini U, Vespasiani G, De Cosmo S. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study.
    Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):110-6

Studio DYDA

  • Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study.
    Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):415-23

Studio HYPOS

  • Giorda CB, Ozzello A, Gentile S, Corsi A, Iannarelli R, Baccetti F, Lucisano G, Nicolucci A, Rossi MC; on behalf the HYPOS-1 Study Group. Incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study.
    J Diabetes and Metabolism 2014;5:344
  • Giorda CB, Ozzello A, Gentile S, Agliloro A, Chiambretti A, Baccetti F, Gentile FM, Lucisano G, Nicolucci A, Rossi MC; HYPOS-1 Study Group of AMD. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.
    Acta Diabetol. 2015 Oct;52(5):845-53

Studio SUBITO!AUDIT

  • Giorda CB, Mulas MF, Manicardi V, Suraci C, Guida P, Marafetti L, Nada E, Gentile S. Factors involved in a rapid and effective normalisation of HbA1c in newly diagnosed type 2 diabetic patients.
    Acta Diabetol. 2013 Feb;50(1):81-7
  • Nicolucci A, Rossi MC, Pintaudi B, Lucisano G, Scardapane M, Gentile S, Bulotta A, Skovlund SE, Vespasiani G, a nome del Gruppo di studio BENCH-D. Il miglioramento continuo della qualità dell’assistenza diabetologia attraverso la valutazione di indicatori clinici e umanistici.
    IHPB 2014;IV(Speciale):1-7

Studio SUBITO-DE

  • Corona G, Giorda CB, Cucinotta D, Guida P, Nada E; Gruppo di studio SUBITO-DE. Sexual dysfunction at the onset of type 2 diabetes:the interplay of depression, hormonal and cardiovascular factors.
    J Sex Med. 2014 Aug;11(8):2065-73

Studio QUASAR

  • Rossi MC, Nicolucci A, Comaschi M, Coscelli C, Cucinotta D, Ceriello A, De Cosmo S, Giorda C, Valentini U, Di Blasi P, Merante D, Vespasiani G. Analisi della correlazione tra aspetti strutturali-organizzativi, misure di processo e risultati dell’assistenza diabetologica. Razionale e disegno dello studio QUASAR.
    MeDia. 2007 mar;7(1):42-48
  • Rossi MC, Nicolucci A, Comaschi M, Coscelli C, Cucinotta D, Ceriello A, De Cosmo S, Giorda C, Otranto I, Pellegrini F, Pomili B, Valentini U, Di Blasi P, Merante D, Vespasiani G. Quali ‘indicatori di qualità utilizzare per la definizione dei profili di cura del diabete? Lo studio QUASAR (Quality Assessment Score and Cardiovascular Outcomes in Italian Diabetes Patients).
    MeDia. 2008 giu;8(2):79-86
  • Rossi MC, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellefrini F, Pomili B, Valentini U, Vespasiani G, Nicolucci A. Il raggiungimento dei target terapeutici nella pratica clinica:i risultati dello studio QUASAR.
    MeDia. 2009 dic;9(4):201-7
  • Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellegrini F, Valentini U, Vespasiani G, Nicolucci A; AMD-QUASAR Study Group. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study.
    Diabetes Care. 2011 Feb;34(2):347-52

Score

Studio START DIAB

  • Gentile S, Ceriello A, Strollo F, on behalf of the AMD START DIAB Study Group. A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?
    Diabetes Res Open J. 2016;2(2):33.44

Gruppo AMD Diabete e nutrizione

  • Giacco R, Costabile G, Fatati G, Frittitta L, Maiorino MI, Marelli G, Parillo M, Pistis D, Tubili C, Vetrani C, Vitale M. Effects of polyphenols on cardio-metabolic risk factors and risk of type 2 diabetes. A joint position statement of the Diabetes and Nutrition Study Group of the Italian Society of Diabetology (SID), the Italian Association of Dietetics and Clinical Nutrition (ADI) and the Italian Association of Medical Diabetologists (AMD). Nutr Metab Cardiovasc Dis. 2020;30(3):355-67

Gruppo AMD Donna

  • Manicardi V, Russo G, Napoli A, Torlone E, Li Volsi P, Giorda CB, Musacchio N, Nicolucci A, Suraci C, Lucisano G, Rossi MC; AMD Annals Study Group. Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016 Oct 3;11(10):e0162960
  • Manicardi V, Rossi MC, Romeo EL, Giandalia A, Calabrese M, Cimino E, Antenucci D, Bollati P, Li Volsi P, Maffettone A, Speroni G, Suraci C, Torlone E, Russo G; on behalf of Gruppo Donna AMD. Gender differences in type 2 diabetes (Italy).
    Ital J Gender-Specific Med. 2016;2(2):60-68
  • Russo G, Pintaudi B, Giorda C, Lucisano G, Nicolucci A, Cristofaro MR, Suraci C, Mulas MF, Napoli A, Rossi MC, Manicardi V. Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus.
    Int J Endocrinol. 2015;2015:957105
  • Rossi MC, Cristofaro MR, Gentile S, Lucisano G, Manicardi V, Mulas MF, Napoli A, Nicolucci A, Pellegrini F, Suraci C, Giorda C; AMD Annals Study Group. Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the AMD Annals initiative.
    Diabetes Care. 2013 Oct;36(10):3162-8

Gruppo AMD Terapia iniettiva

2023

  • Felice Strollo, Ersilia Satta, Luisa Borgia 4 and Sandro Gentile. Insulin-induced lipohypertrophy and factors affecting it in children and adolescents with type 1 diabetes mellitus: Review of the literature from the past 12 years: An appraisal and extension to adult subjects. World Journal of Advanced Research and Reviews, 2023, 17(01), 596–604. DOI: https://doi.org/10.30574/wjarr.2023.17.1.0074
  • Sandro Gentile, Ersilia Satta, Giuseppina Guarino and Felice Strollo 3 on behalf of the AMD-OSDI Study Group on Injection Technique. Lipodystrophies from Insulin Injection: An Update of the Italian Consensus Statement of AMD-OSDI Study Group on Injection Technique. Diabetology 2023, 4, 119–127. https://doi.org/10.3390/diabetology4010013
  • Sandro Gentile, Giuseppina Guarino, Felice Strollo. Unexpected evolution of a monster case of insulin-induced skin lipohypertrophy. Diab Res Clin Pract 206 (2023) 110994.  https://doi.org/10.1016/j.diabres.2023.110994
  • Monda VM, Voci C, Strollo F, Passaro A, Greco S, Monesi M, Bigoni R, Porcellati F, Piani D, Satta E, Gentile S. Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy. Diabetes Ther. 2023 Dec;14(12):2127-2142. doi: 10.1007/s13300-023-01472-8. Epub 2023 Oct 6. PMID: 37801224; PMCID: PMC10597965. https://doi.org/10.1007/s13300-023-01472-8.
  • Huang J, Yeung AM, Kerr D, Gentile S, Heinemann L, Al-Sofiani ME, Joseph JI, Seley JJ, Klonoff DC. Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks. Endocr Pract. 2023 Aug;29(8):670-677. doi: 10.1016/j.eprac.2023.04.006. Epub 2023 Apr 23. PMID: 37098370. https://doi.org/10.1016/j.eprac.2023.04.006
  • Sandro Gentile,Felice Strollo, Giuseppina Guarino, Ersilia Satta, Emilia Martedì, Domenica Oliva, Carmine Martino, Clementina Brancario, Clelia Lamberti, Marco Corigliano, Gerardo Corigliano, Marco Piscopo, Rosa Simonetti, Sara Colarusso, Miryam Ciotola, Pasqualino Calatola, Maria Rosaria Improta, Alessandra Fusco. Effect of dulaglutide treatment in aged subjects with type 2 diabetes mellitus and fatty liver disease. J Diab Metab Disorder. 2023;10(1):56‒64. https://www.nefrocenterresearch.it/wp-content/uploads/2024/03/Effect-of-dulaglutide-treatment.pdf
  • Tiffany Tian, Rachel E. Aaron, Jingtong Huang, Andrea M. Yeung, Jannet Svensson, Sandro Gentile, Angus Forbes, Lutz Heinemann, Jane Jeffrie Seley, David Kerr. David C. Klonoff Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. 2023 Diabetes Technology Society Article reuse guidelines: sagepub.com/journals-permissions DOI: 10.1177/19322968231187661 journals. sagepub.com/home/dst

2022

  • Felice Strollo, Ersilia Satta and Sandro Gentile. Insulin Injection-Related Skin Lipodystrophies: Blemish or Pathology? Diabetology 2022, 3, 615–619. https://doi.org/10.3390/diabetology3040047
  • Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfarone C, Giordano L, Loiacono F, Capece M, Lamberti R, Strollo F; Nefrocenter, Nyx Start-up, AMD-OSDI Study Group on Injection Techniques, ANIAD. Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies? Diabetes Ther. 2023 Jan;14(1):179-191. doi: 10.1007/s13300-022-01341-w. Epub 2022 Dec 6. PMID: 36472805; PMCID: PMC9735184. https://doi.org/10.1007/s13300-022-01341-w
  • Sandro Gentile, Ersilia Satta, Giuseppina Guarino, Carmine Romano, Adalgisa Maffettone, Erika Eliana Henke, Elvira Donnarumma, Romina Castellano, Salvatore Izzo, Iolanda Manzo, Felice Strollo. A Journey Through Guidelines, Consensus, Curriculum of Educators and Clinical Practice on Insulin-Induced Skin Lipohypertrophy: From the Earth to the Moon. Medical Research Archives, 2022 [online] 10(9). https://doi.org/10.18103/mra.v10i9.3019
  • Monda VM, Gentile S, Porcellati F, Satta E, Fucili A, Monesi M, Strollo F. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes. Adv Ther. 2022 Nov;39(11):4837-4846. doi: 10.1007/s12325-022-02310-2. Epub 2022 Sep 16. PMID: 36112311; PMCID: PMC9525351. https://doi.org/10.1007/s12325-022-02310-2
  • Sandro Gentile, Giuseppina Guarino, Ersilia Satta, Carmine Romano, Felice Strollo. Why 100-Years After the Discovery of Insulin and the Appearance of Insulin-Induced Lipodystrophy: Are We Still Struggling with this Nasty Complication? Diabetes Res Open J. 2022; 8(2): 23-29. doi: 10.17140/DROJ-8-156. https://www.nefrocenterresearch.it/wp-content/uploads/2022/06/Why-100-Years-After-the-Discovery-of-Insulin-and-the-Appearance-of-Insulin-Induced-Lipodystrophy-Are-We-Still-Struggling-with-this-Nasty-Complication-DROJ-8-156.pdf
  • Strollo F, Gentile S, Pipicelli AMV, Mambro A, Monici M, Magni P. Space Flight-Promoted Insulin Resistance as a Possible Disruptor of Wound Healing. Front Bioeng Biotechnol. 2022 May 13;10:868999. doi: 10.3389/fbioe.2022.868999. PMID: 35646861; PMCID: PMC9136162. DOI: 10.3389/fbioe.2022.868999
  • È disponibile online Diabetology Feature Papers 2022, una Printed Edition of the Special Issue Published in Diabetology, curate da Peter Clifton, che contiene due articoli sulle tecniche iniettive:
  • Gentile S, Satta E, Guarino G, and Strollo F; on behalf of the AMD-OSDI Study Group on Injection Technique. Lipodystrophies from Insulin Injection: An Update of the Italian Consensus Statement of AMD-OSDI Study Group on Injection Technique. (disponibile anche in: Diabetology 2023;4:119-127)
  • Strollo F, Satta E, Gentile S.Insulin Injection-Related Skin Lipodystrophies: Blemish or Pathology? (disponibile anche in: Diabetology 2022;3:615-619).
  • Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capece M, Lamberti R, Strollo F; on behalf of Nefrocenter and Nyx Start-up, AMD-OSDI Study Group on Injection Techniques, and ANIAD. The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study. Adv Ther. 2022 Mar 19. doi: 10.1007/s12325-022-02105-5. Online ahead of print.

2021

  • Di Bartolo P, Eckel RH, Strollo S, Gentile S. Hundred-year experience with insulin and lipohypertrophy: An unresolved issue. Diabetes Res Clin Pract. 2021 Aug; 178:108924. doi: 10.1016/j.diabres.2021.108924. Epub 2021 Jun 18.
  • Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Giordano L, Loiacono F, Capace M, Lamberti R, Strollo F; AMD-OSDI Study Group on Injection Technique; Nefrocenter Research and Nyx Start-Up Study Group. The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study. Diabetes Ther. 2021 Sep;12(9):2557-2569.
  • Gentile S, Satta E, Strollo F, Guarino G, Romano C, Della Corte T, Alfarone C; Study Group AMD-OSDI on Injection Technique, and Nefrocenter Research & Nyx Start-up. Insulin-induced skin lipohypertrophies: A neglected cause of hypoglycemia in dialysed individuals with diabetes. Diabetes Metab Syndr. 2021; 15:102145.
  • Gentile S, Satta E, Capece M, Guarino G, Della Corte T, Romano C, Marino G, Pasquarella M, Alfarone C, Loiacono F, Lamberti R and Strollo F; AMD-OSDI Study Group on Injection Technique and Nefrocenter Research & Nyx Start-Up Study Group. Integrated Approach to Cardio-Vascular Risk in Insulin-Treated People with Diabetes based on the “Heart Project” and on Metabolic Complications Expected from Incorrect Injection Practice-Related Lipohypertrophy. J Diabet Res Rev. Rep. 2021;3(3):2-8.
  • Gentile S, Guarino G, Cuomo G, Lamberti C, Della Corte T, Stile L.A, Strollo F, and On behalf of AMD-OSDI Injection Technique Study Group and Nefrocenter & Nyx Start-up Study Group. Videocapillaroscopy, Insulin-Induced Skin Lipohypertrophy, and Bruising: A Preliminary Approach.  J Diabet Res Rev Rep. 2021;3(2):1-4.
  • Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them? Diabetes Obes Metab. 2020 Dec;22(12):2507-2508. doi: 10.1111/dom.14170. Epub 2020 Aug 27. PMID: 32790021; PMCID: PMC7436911. DOI: 10.1111/dom.14170
  • Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, Romano C, Alfrone C, Strollo F, on behalf of AMD-OSDI Study Group on Injection Technique, Nefrocenter Research and Nyx Start-Up. Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study. Diabetes Ther. 2021. doi.org/10.1007/s13300-021-01006-0.
  • Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Romano C, Alfrone C, Lmberti C, Strollo F; AMD-OSDI Study Group. Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey. Diabetes Ther. 2021 Mar 9. doi: 10.1007/s13300-021-01026-w. Online ahead of print.
  • Strollo F, Furia A, Verde P, Bellia A, Grussu M, Mambro A, Petrelli MD, Gentile S. Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: A new chance to improve the directives? Diabetes Res Clin Pract. 2021 Feb 01; 172:108638.
  • Gentile S, Guarino G, Strollo F. How to treat improper insulin injection-related lipohypertrophy: A 3-year follow-up of a monster case and an update on treatment. Diabetes Res Clin Pract. 2021 Jan; 171:108534. doi: 10.1016/j.diabres.2020.108534. Epub 2020 Nov 10. PMID: 33181200. DOI: 10.1016/j.diabres.2020.108534
  • Gentile S, Guarino G, Strollo F. A Cry of Pain for Painless Insulin Lipohypertrophy. J Diabet Res Rev ReP, 2020. of Diabetes Research Reviews & Reports. SRC/JDRRR/102. https://www.researchgate.net/publication/348712682_A_Cry_of_Pain_for_Painless_Insulin_Lipohypertrophy

2020

  • Gentile S, Guarino G, Della Corte T, Marino G, Fusco A, Corigliano G, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Russo V, Simonetti R, Satta E, Romano C, Vaia S, Strollo F; AMD-OSDI Study Group on Injection Techniques; Nefrocenter Network and Nyx Start-up Study Group. Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes. Diabetes Ther. 2020 Nov 21. doi: 10.1007/s13300-020-00954-3. Online ahead of print.
  • Gentile S, Guarino G, Strollo F. How to treat improper insulin injection-related lipohypertrophy: A 3-year follow-up of a monster case and an update on treatment. Letter to the Editor. Diabetes Res Clin Pract. 2020 Nov 9;108534. doi: 10.1016/j.diabres.2020.108534. Online ahead of print.
  • Della-Corte T, Gentile S, Di Blasi V, Guarino G, Corigliano M, Cozzolino G, Fasolino A, Martino C, Improta MR, Oliva D, Lamberti C, Vecchiato A, Vaia S, Satta E, Romano C, Alfarone C, Strollo F; Nefrocenter & Nyx Start-Up Research Study Group. Is pizza sutable to type 1 diabetes? A real life identification of best compromise between taste and low glycemic index in patients on insulin pump. Diabetes Metab Syndr. 2020 May-Jun;14(3):225-227. doi: 10.1016/j.dsx.2020.03.003. Epub 2020 Mar 12. PMID: 32240944. DOI: 10.1016/j.dsx.2020.03.003
  • Della Corte T, Gentile S, Guarino G, Satta E, Romano C, Alfarone C, Strollo F; Nefrocenter & Nyx Start-Up Research Study Group. HOW to make a mix of low glycemic index flours for a good Neapolitan pizza for patients with diabetes. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):459-462. doi: 10.1016/j.dsx.2020.04.030. Epub 2020 Apr 24. PMID: 32380405. DOI: 10.1016/j.dsx.2020.04.030
  • Gentile S, Strollo F, Ceriello A. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used). Diabetes Res Clin Pract. 2020 Apr;162:108137. doi: 10.1016/j.diabres.2020.108137. Epub 2020 Apr 4. PMID: 32259611; PMCID: PMC7270733. DOI: 10.1016/j.diabres.2020.108137
  • Gentile S, Strollo F, Ceriello A. The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak. Diabetes Ther. 2020 Jun;11(6):1191-1193. doi: 10.1007/s13300-020-00824-y. Epub 2020 Apr 29. PMID: 32351631; PMCID: PMC7189357. DOI: 10.1007/s13300-020-00824-y
  • Gentile S, Mambro A, Strollo F. Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy. Diabetes Res Clin Pract. 2020 Jun;164:108195. doi: 10.1016/j.diabres.2020.108195. Epub 2020 May 12. PMID: 32407747; PMCID: PMC7214347. DOI: 10.1016/j.diabres.2020.108195

2019

  • Gentile, F. Strollo, E. Satta, T. Della Corte, C. Romano, G. Guarino, on behalf of Nefrocenter Research Study Group: Nephrologists, Diabetologists, Nurses. Insulin-induced lypodistrophy in hemodialyzed patients: A new challenge for nephrologists? Diabetes Metab Syndr. 2019;13(6):3081-4
  • Gentile S, Strollo F, Satta E, Della Corte T, Romano C, Guarino G; Nefrocenter Research Study Group: Nephrologists, Diabetologists, Nurses. Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach. Diabetes Ther. 2019 Jun 20. doi: 10.1007/s13300-019-0650-2. [Epub ahead of print]
  • Improta MR, Strollob F, Gentile S; AMD-OSDI Study Group on Injection Technique. Lessons learned from an unusual case of severe hypoglycemia. Diabetes Metab Syndr 2019;13(2):1237-1239. DOI: 10.1016/j.dsx.2019.01.033
  • Gentile, F. Strollo, G. Guarino. Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest? Diabetes Metab Syndr 2019;13(1):682-686. DOI: 10.1016/j.dsx.2018.11.042
  • Gentile, F. Strollo, E. Satta, T. Della-Corte, C. Romano, G. Guarino, on behalf of Nefrocenter Research Study Group: Nephrologists, Diabetologists, Nurses. Insulin-induced lypodistrophy in hemodialyzed patients: A new challenge for nephrologists? Diabetes Metab Syndr. 2019;13(6):3081-4. DOI: 10.1016/j.dsx.2019.11.005
  • Strollo F, Simons R, Mambro A, Strollo G, Gentile S. Continuous glucose monitoring for in-flight measurement of glucose levels of insulin-treated pilots. Aerosp Med Hum Perform. 2019; 90(8):735–737. DOI: 10.3357/AMHP.5315.2019
  • Gentile S, Strollo F, Guarino G; Diabetologists; Nurses. Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest? Diabetes Metab Syndr. 2019 Jan-Feb;13(1):682-686. doi: 10.1016/j.dsx.2018.11.042. Epub 2018 Nov 16. PMID: 30641790. DOI: 10.1016/j.dsx.2018.11.042

2018

  • Lanati EP, La Malfa P, Iorio A, Mennini FS, Fanelli F, Gentile S. Analisi di impatto sul budget di differenti analoghi ad azione rapida dell’insulina in Italia. Global & Regional Health Technology Assessment. 2018;2018. doi: 10.1177/22842403187594182017
  • Gentile S, Strollo F, Della Corte T, Marino G, Guarino G. Insulin related lipodystrophic lesions and hypoglycemia: Double standards? Diabetes Metab Syndr 2018;12(5):813-818. DOI: 10.1016/j.dsx.2018.04.023
  • Gentile S, Fusco A, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D’Alessandro A, Russo V, Guarino G, Marino G, Corigliano G, Strollo F. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence. Expert Opin Drug Saf 2018;17(5):445-450. DOI: 10.1080/14740338.2018.1453495
  • Fusco A, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedì E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D’Alessandro A, Russo V. Guarino G, Marino G, Strollo F, Corigliano G, Gentile S. Despite being Apparently Equal, Concentrated Lispro-200 Performs Metabolically and Subjectively Better than Lispro-100. Divers and Equal Health and Care 2018;15(2):57-65. https://www.primescholars.com/articles/despite-being-apparently-equal-concentrated-lispro200-performs-metabolically-and-subjectively-better-than-lispro100-94961.html
  • Gentile S, Strollo F; on behalf of the Nefrocenter Research Study Group. Cost saving effects of a short-term educational intervention entailing lower hypoglycaemic event rates in people with type 1 diabetes and lipo-hypertrophy Diab Res Clon Pract 2018;143:220-21. DOI: 10.1016/j.diabres.2018.07.030
  • Gentile S, Guarino G, Martedì, Della Corte E, Strollo F; on behalf of the Italian Study Group on Injection Techniques. Considerations on Lipoatrophic Skin Lesions Far from Insulin Injection Sites. Diabetes Res Clin Pract. 2018 Jun; 140:347-350. DOI: 10.1016/j.diabres.2018.04.019
  • Gentile S, Strollo F, Della Corte T, Guarino G. Insulin related lipodystrophic lesions and hypoglycemia: double standards? Diabetes Metab Syndr. 2018 Sep;12(5):813-818. doi: 10.1016/j.dsx.2018.04.023.
  • Guarino G, Ragozzino G, Della Corte T, Fontana S, Strollo F, Cecaro M, and Gentile S. Selenium Supplementation in Obese Patients with Subclinical Hypothyroidism and Type 2 Diabetes.. J Nutri Health Sci 5(2): 202. doi:10.15744/2393-9060.5.202
  • Gentile S, Strollo F, Corte TD, Marino G, Guarino G; Italian Study Group on Injection Techniques. Skin complications of insulin injections: A case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018 Apr;138:284-287. doi: 10.1016/j.diabres.2018.02.005.
  • Lepore G, Bonfanti R, Bozzetto L, Di Blasi V, Girelli A, Grassi G, Iafusco D, Laviola L, Rabbone I, Schiaffini R, Bruttomesso D; Italian Study Group on the Diffusion of CSII. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):335-342. doi: 10.1016/j.numecd.2017.12.001. Epub 2017 Dec 9. PMID: 29428572.

2017

2016

  • Gentile S, Strollo F, De Rosa N, Grassi G , Lalli C, Lo Grasso G, Marcone TAM, Sudano M, Gentile L, Giancaterini A, Tatti P, Tonutti L, De Riu S, Cucco L, Speese K, Botta A, Armentano V, Chiandetti R, Garrapa G. Injection-Related Local Side Effects in the Treatment of Diabe­tes Mellitus: A Methodological Approach and Possible Solutions. Consensus Statement of AMD-OSDI Study Group on Injection Technique Diabetic Complications. Diabetes Ther 2016;7(3):401-9. https://www.researchgate.net/publication/309297809_AMD-OSDI_Consensus_on_Injection_Techniques_for_People_with_Diabetes_Mellitus
  • Gentile S, Strollo F. Subcutaneus nodules during treatment with exenatide long-actin once-weekly formulation: an ultrasound evaluation. Divers Equal Health Care 2016;13(4):313-318. https://www.primescholars.com/articles/subcutaneous-nodules-during-treatment-with-anexenatide-longactin-onceweekly-formulationan-ultrasound-evaluation.pdf
  • Gentile S, Grassi G, Armentano V, Botta A, Cucco L, De Riu S, De Rosa N, Garrapa G, Gentile L, Giancaterini A, Lalli C, Lo Grasso G, Marcone TAM, Chiandetti R, Speese K, Sudano M, Tatti P, Tonutti L, Branca MT and Strollo F. AMD-OSDI Consensus on Injection Techniques for People with Diabetes Mellitus. Med Clin Rev. 2016, 2:3 doi: 10.21767/2471-299X.1000034
  • Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, Smith MJ, Wellhoener R, Bode BW, Hirsch IB, Kalra S, Ji L, Strauss KW. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016 Sep;91(9):1231-55. doi: 10.1016/j.mayocp.2016.06.010.
  • Strollo F, Guarino G, Armentano V, Clemente G, Martedì E, De Riu S, Gaeta I, Corigliano G, Ceriello A, Gentile S; on behalf of AMD-OSDI Italian Study Group on Injection Techniques. Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign. Diabetes Res Open J 2016; 2(1):24-32. https://www.researchgate.net/publication/306276074_Unexplained_Hypoglycaemia_and_Large_Glycaemic_Variability_Skin_Lipohypertrophy_as_a_Predictive_Sign
  • Gentile S, Strollo F, Ceriello A, on behalf of the AMD-OSDI Injection Technique Study Group. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Diabetes Ther 2016. doi: 10.1007/s13300-016-0187-6
  • Gentile S, Strollo F, Ceriello A. Insulin treatment in people with diabetes mellitus and chronic liver disease. Ann Hepatol. 2016 Mar-Apr;15(2):287-8. doi: 10.5604/16652681.1193728.
  • Gentile S, Guarino G, Strollo F, Romano M, Genovese S, Masarone M, Ceriello A. Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2016; 113:179-186. DOI: 10.1016/j.diabres.2015.12.006
  • Gentile S, Strollo F, Guarino G, Giancaterini A, Ames PRJ, Sp.eese K, Guida P, Strauus K. Factors Hindering Correct Identification of Unapparent Lipohypertrophy.  J Diabetes Metab Disord Control 2016, 3(2):00065. https://medcraveonline.com/JDMDC/factors-hindering-correct-identification-of-unapparent-lipohypertrophy.html
  • Gentile S, Strollo F, Ceriello A. Insulin Shot Dependent Lipodystrophy: Evidence, Uncertainties and Current Terminology Overlaps. J Diabetes Metab Disord Control 2016;3(2):00065. https://medcraveonline.com/JDMDC/JDMDC-03-00067.pdf
  • Gentile S, Strollo F, Ceriello A. Lipodistrophy and associated risk factors in insulin treated people with diabetes. Int Int J Endocrinol Metab. 2016 Apr 26;14(2):e33997. doi: 10.5812/ijem.33997. eCollection 2016 Apr.
  • Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F, and AMD-OSDI Italian Injection Technique Study Group. Suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin treated people with diabetes. Springerplus. 2016 May 5:5:563. doi: 10.1186/s40064-016-1978-y. eCollection 2016.
  • Gentile S, Strollo F, Ceriello A, on behalf of the AMD-OSDI Injection Technique Study Group. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear Diabetes Ther. 2016 Sep;7(3):401-9. doi: 10.1007/s13300-016-0187-6. Epub 2016 Jul 25.2015

2015

  • Guarino G, Della Corte T, Sofia M, Carbone L, Marino G, Martedì E, Gentile S. Metabolic effects of the association Berberis aristata/Silybum marianum: a preliminary double-blind, placebo-controlled study in obese patients with type 2 diabetes. Nutrafoods 2015;14(4):181-188. https://www.researchgate.net/publication/286649711_Metabolic_effects_of_the_association_Berberis_aristataSilybum_marianum_a_preliminary_double-blind_placebo-controlled_study_in_obese_patients_with_type_2_diabetes
  • Documento di consenso su “Gestione e utilizzo dei sistemi iniettivi dell’insulina in ospedale” Il Giornale di AMD 2015;18:2S:4-20, maggio 2015
  • Gentile S. Severe and protracted iatrogenic hypoglycemia in the course of diabetes and liver cirrhosis: Case report and literature review. G It Diabetol Metab 2015;35:22-26. https://www.researchgate.net/publication/297508083
  • Bruttomesso D, Laviola L, Lepore G. et al. and the Italian Study Group on Diffusion of CSII. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey. Diabetes Technol Ther. 2015 Feb;17(2):96-104. doi: 10.1089/dia.2014.0242. Epub 2014 Dec 5. PMID: 25479035. https://doi.org/10.1089/dia.2014.0242 Author List: Mammì, M. Bruzzese, M. Schettino, M.G. Nuzzo, V. Di Blasi, R. Fresa, C. Lambiase, D. Iafusco, A. Zanfardino, S. Confetto, L. Bozzetto, G. Annuzzi, A. Alderisio, G. Riccardi, S. Gentile, G. Marino, G. Guarino, S. Zucchini, G. Maltoni, T. Suprani, V. Graziani, M. Nizzoli S. Acquati, R. Cavani, S. Romano, M. Michelini, E. Manicardi, R. Bonadonna, A. Dei Cas, E. Dall’aglio, M. Papi, S. Riboni, V. Manicardi, E. Manicardi, E. Manicardi, V. Pugni, A. Lasagni, M.E. Street, U. Pagliani, C. Rossi, R. Assaloni, B. Brunato, C. Tortul, G. Zanette, P. Li Volsi, M. Zanatta, L. Tonutti, S. Agus, M.A. Pellegrini, P. Ceccano, G. Pozzilli, Beretta Anguissolac, R. Buzzetti, C. Moretti, G. Leto, P. Pozzilli, S. Manfrini, A.R. Maurizi, S. Leotta, M. Altomare, S. Abbruzzese, S. Carletti, C. Suraci, S. Filetti, M.L. Manca Bitti, S. Arcano, M.G. Cavallo, M. De Bernardinis, D. Pitocco, S. Caputo, A. Rizzi, A. Manto, R. Schiaffini, M. Cappa, D. Benevento, S. Frontoni, I. Malandrucco, S. Morano, T. Filardi, D. Lauro, M.A. Marini, E. Castaldo, D. Sabato, F. Tuccinardi, E. Forte, P. Viterbori, C. Arnaldi, N. Minuto, G. d’Annunzio, A. Corsi, R. Rota, C. Scaranna, R. Trevisan, U. Valentini, A. Girelli, S. Bonfadini, E. Zarra, A. Plebani, E. Prandi, B. Felappi, A. Rocca, E. Meneghini, P. Galli, P. Ruggeri E. Carrai, L. Fugazza, V. Baggi, D. Conti, E. Bosi, A. Laurenzi, A. Caretto, C. Molinari, E. Orsi, V. Grancini, V. Resi, R. Bonfanti, V. Favalli, C. Bonura, A. Rigamonti, M. Bonomo, F. Bertuzzi, B. Pintaudi, O. Disoteo, G. Perseghin, S. Perra, L. Chiovato, P. De Catax, F. Zerbini, E. Lovati, M. Laneri, L. Guerraggio, A.C. Bossi, V. De Mori, M. Galetta, I. Meloncelli, A. Aiello, S. Di Vincenzo, A. Nuzzi, E. Fraticelli, E. Ansaldi, M. Battezzati, M. Lombardi, M. Balbo, R. Lera, A. Secco, V. De Donno, F. Cadario, S. Savastio, C. Ponzani, G. Aimaretti, I. Rabbone, G. Ignaccolo, D. Tinti, F. Cerutti, F. Bari, F. Giorgino, E. Piccinno, O. Zecchino, M. Cignarelli, O. Lamacchia, G. Picca, S. De Cosmo, A. Rauseo, L. Tomaselli, A. Tumminia, C. Egiziano, A.M. Scarpitta, F. Maggio, F. Cardella, R. Roppolo, V. Provenzano, M. Fleres, A. Scorsone, A. Scatena, G. Gregori, S. Lucchesi, F. Gadducci, S. Di Cianni. S. Pancani, S. Del Prato, M. Aragona, I. Crisci, A. Calianno, B. Fattor, D. Crazzolara, P. Reinstadler, S. Longhi, G. Incelli, S. Rauch, T. Romanelli, M. Orrasch, V. Cauvin, R. Franceschi, C. Lalli, A. Pianta, A. Marangoni, C.N. Aricò, N. Marin, N. Nogara, N. Simioni, A. Filippi, G.L. Gidoni Guarneri, M.L. Contin M.L, A.P. Decata, L. Bondesan, L. Confortin, A. Coracina, S. Lombardi, S. Costa Padova, E. Cipponeri, R. Scotton, S. Galasso, F. Boscari, M.S. Zanon, C. Vinci, G. Lisato, L. Gottardo, E. Bonora, M. Trombettac, C. Negri, C. Brangani, C. Maffeis, A. Sabbion, M. Marigliano.
  • Briatore L. “Insulina: dove, come, quanta?”, ovvero: i modi più bizzarri per (non) iniettare l’insulina. Il Giornale di AMD 2015; 18:197-199. https://www.jamd.it/wp-content/uploads/2017/02/2015_3_9.pdf
  • Gentile S, Giancaterini A, Cucco L, Lo Grasso G, Porcellati F, Laviola L.Raccomandazioni per una corretta tecnica iniettiva e per la prevenzione delle lipodistrofie e del rischio di punture accidentali Tavolo di lavoro AMD-OSDI-SID. Il Giornale di AMD, 2015;18:209-217. https://www.aemmedi.it/files/Linee-guida_Raccomandazioni/2015/Documento_di_consenso_ 2015.pdf
  • Gentile S. Il «puzzle» della terapia insulinica tra ospedale e territorio: contributo normativo. Il Giornale di AMD, 2015;18:218-223. https://www.jamd.it/wp-content/uploads/2017/02/2015 _3_13. pdf
  • Marcone TAM. Sconfitto un pregiudizio nei diabetici obesi: efficacia, sicurezza e preferenza dell’ago da insulina di 4 mm/32 g. Il Giornale di AMD 2015; 18:235. https://www.jamd.it/wp-content/uploads/2017/02/2015_3_13.pdf
  • Gentile S, Strollo F, Viazzi F, Russo G, Piscitelli P, Ceriello A, Giorda C, Guida P, Fioretto P, Pontremoli R, De Cosmo S, The Amd-Annals Study Group. Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions. J Diabetes Res. 2018 Sep 19; 2018:7153087. doi: 10.1155/2018/7153087. PMID: 30327785; PMCID: PMC6169213.
  • Strollo F, Gentile S, Strollo G, Mambro A, Vernikos J. Recent Progress in Space Physiology and Aging. Front Physiol. 2018 Nov 12; 9:1551. doi: 10.3389/fphys.2018.01551. PMID: 30483144; PMCID: PMC6240610. DOI: 10.3389/fphys.2018.01551
  • Gentile S, Strollo F, Corte TD, Marino G, Guarino G; Italian Study Group on Injection Techniques. Skin complications of insulin injections: A case presentation and a possible explanation of hypoglycaemia. Diabetes Res Clin Pract. 2018 Apr;138:284-287. doi: 10.1016/j.diabres.2018.02.005. Epub 2018 Feb 8. PMID: 29427696. DOI: 10.1016/j.diabres.2018.02.005

2014

  • Gentile S. A case of severe hypoglycemia frequently associated with errors of insulin injection technique. G It Diabetol Metab 2014; 34:214-219 https://www.researchgate. net/ publication/ 292419376

2013

  • Strollo F, Guarino G, Marino G, Paolisso G, Gentile S. Different prevalence of metabolic control and chronic complication rate according to the time of referral to a diabetes care unit in the elderly. Acta Diabetol. 2014;51(3):447-53. doi: 10.1007/s00592-013-0537-z. Epub 2013 Dec 24. PMID: 24366424

 

Gruppo AMD Terapia personalizzata

  • Ceriello A, Armentano V, De Micheli A, Gallo M, Perriello G, Gentile S. Documento di consenso. La personalizzazione della terapia: innovazione nella gestione del paziente con diabete di tipo 2.
    Il Giornale di AMD. 2011 gen-mar;14(1):35-45
  • Ceriello A, Gallo M, Armentano V, Perriello G, Gentile S, De Micheli A; Associazione Medici Diabetologi. Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach.
    Diabetes Technol Ther. 2012 Apr;14(4):373-8
  • Ceriello A, Gallo M, Gentile S, Giorda CB, De Micheli A; Associazione Medici Diabetologi. To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) ‘personalised’?
    Diabetologia. 2012 Oct;55(10):2853-5
  • Esposito K, Gentile S, Candido R, De Micheli A, Gallo M, Medea G, Ceriello A; Associazione Medici Diabetologi. Management of hyperglycemia in type 2 diabetes: evidence and uncertainty.
  • Gallo M, De Micheli A, Medea G. Applicazioni pratiche dell’algoritmo terapeutico AMD: ruolo del pioglitazone.
  • Assaloni R, Gallo M, Di Bartolo P, Aiello A, Ceriello A. La qualità di cura nel diabete: appropriatezza e personalizzazione.
  • Gallo M, Mannucci E, De Cosmo S, Gentile S, Candido R, De Micheli A, Di Benedetto A, Esposito K, Genovese S, Medea G, and Ceriello A., on behalf of Associazione Medici Diabetologi (AMD). Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.
  • Gallo M, Gentile S, De Cosmo S, Mannucci E, De Micheli A, Genovese S, Candido R, Di Benedetto A, Esposito K, Medea G e Ceriello A, a nome del Gruppo Terapia Personalizzata di AMD. I risultati di una survey internazionale: un’iniziativa di AMD.
    Il Giornale di AMD. 2015 lug-sett;18:203-8
  • Ceriello A, Gallo M. Authors comments on the article “Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach”.
    Diabetes Forum Austria 2015:26-28